Literature DB >> 27957611

Barrier function in the peripheral and central nervous system-a review.

A K Reinhold1, H L Rittner2.   

Abstract

The peripheral (PNS) and central nervous system (CNS) are delicate structures, highly sensitive to homeostatic changes-and crucial for basic vital functions. Thus, a selection of barriers ensures the protection of the nervous system from noxious blood-borne or surrounding stimuli. In this chapter, anatomy and functioning of the blood-nerve (BNB), the blood-brain (BBB), and the blood-spinal cord barriers (BSCB) are presented and the key tight junction (TJ) proteins described: claudin-1, claudin-3, claudin-5, claudin-11, claudin-12, claudin-19, occludin, Zona occludens-1 (ZO-1), and tricellulin are by now identified as relevant for nerval barriers. Different diseases can lead to or be accompanied by neural barrier disruption, and impairment of these barriers worsens pathology. Peripheral nerve injury and inflammatory polyneuropathy cause an increased permeability of BNB as well as BSCB, while, e.g., diseases of the CNS such as amyotrophic lateral sclerosis, multiple sclerosis, spinal cord injury, or Alzheimer's disease can progress and worsen through barrier dysfunction. Moreover, the complex role and regulation of the BBB after ischemic stroke is described. On the other side, PNS and CNS barriers hamper the delivery of drugs in diseases when the barrier is intact, e.g., in certain neurodegenerative diseases or inflammatory pain. Understanding of the barrier - regulating processes has already lead to the discovery of new molecules as drug enhancers. In summary, the knowledge of all of these mechanisms might ultimately lead to the invention of drugs to control barrier function to help ameliorating or curing neurological diseases.

Entities:  

Keywords:  Alzheimer’s disease; Amyotrophic lateral sclerosis; Barrier opening; Blood–brain barrier; Blood–nerve barrier; Blood–spinal cord barrier; Claudin; Drug delivery; Inflammatory polyneuropathy; Ischemic stroke; Multiple sclerosis; Nerve injury; Occludin; Spinal cord injury; Tight junction; Tricellulin; ZO-1

Mesh:

Substances:

Year:  2016        PMID: 27957611     DOI: 10.1007/s00424-016-1920-8

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  112 in total

1.  Glycogen Synthase Kinase 3 (GSK-3) influences epithelial barrier function by regulating occludin, claudin-1 and E-cadherin expression.

Authors:  Eric A Severson; Mike Kwon; Roland S Hilgarth; Charles A Parkos; Asma Nusrat
Journal:  Biochem Biophys Res Commun       Date:  2010-07-02       Impact factor: 3.575

2.  Deposits of IgG and C3 in the spinal cord and motor cortex of ALS patients.

Authors:  H Donnenfeld; R J Kascsak; H Bartfeld
Journal:  J Neuroimmunol       Date:  1984-02       Impact factor: 3.478

3.  Biphasic opening of the blood-brain barrier following transient focal ischemia: effects of hypothermia.

Authors:  Z G Huang; D Xue; E Preston; H Karbalai; A M Buchan
Journal:  Can J Neurol Sci       Date:  1999-11       Impact factor: 2.104

4.  Schwann cell-derived Desert hedgehog controls the development of peripheral nerve sheaths.

Authors:  E Parmantier; B Lynn; D Lawson; M Turmaine; S S Namini; L Chakrabarti; A P McMahon; K R Jessen; R Mirsky
Journal:  Neuron       Date:  1999-08       Impact factor: 17.173

5.  Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation.

Authors:  Hania Kebir; Katharina Kreymborg; Igal Ifergan; Aurore Dodelet-Devillers; Romain Cayrol; Monique Bernard; Fabrizio Giuliani; Nathalie Arbour; Burkhard Becher; Alexandre Prat
Journal:  Nat Med       Date:  2007-09-09       Impact factor: 53.440

6.  Tight junction proteins claudin-2 and -12 are critical for vitamin D-dependent Ca2+ absorption between enterocytes.

Authors:  Hiroki Fujita; Kotaro Sugimoto; Shuichiro Inatomi; Toshihiro Maeda; Makoto Osanai; Yasushi Uchiyama; Yoko Yamamoto; Takuro Wada; Takashi Kojima; Hiroshi Yokozaki; Toshihiko Yamashita; Shigeaki Kato; Norimasa Sawada; Hideki Chiba
Journal:  Mol Biol Cell       Date:  2008-02-20       Impact factor: 4.138

7.  Blood-brain barrier alterations in the cerebral cortex in experimental autoimmune encephalomyelitis.

Authors:  Mariella Errede; Francesco Girolamo; Giovanni Ferrara; Maurizio Strippoli; Sara Morando; Valentina Boldrin; Marco Rizzi; Antonio Uccelli; Roberto Perris; Caterina Bendotti; Mario Salmona; Luisa Roncali; Daniela Virgintino
Journal:  J Neuropathol Exp Neurol       Date:  2012-10       Impact factor: 3.685

8.  Claudin-16 and claudin-19 interact and form a cation-selective tight junction complex.

Authors:  Jianghui Hou; Aparna Renigunta; Martin Konrad; Antonio S Gomes; Eveline E Schneeberger; David L Paul; Siegfried Waldegger; Daniel A Goodenough
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

9.  Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice.

Authors:  Mikio Furuse; Masaki Hata; Kyoko Furuse; Yoko Yoshida; Akinori Haratake; Yoshinobu Sugitani; Tetsuo Noda; Akiharu Kubo; Shoichiro Tsukita
Journal:  J Cell Biol       Date:  2002-03-11       Impact factor: 10.539

10.  Overexpression of netrin-1 increases the expression of tight junction-associated proteins, claudin-5, occludin, and ZO-1, following traumatic brain injury in rats.

Authors:  Jianfeng Wen; Suokai Qian; Qifan Yang; Lei Deng; Ye Mo; Yuefei Yu
Journal:  Exp Ther Med       Date:  2014-07-01       Impact factor: 2.447

View more
  78 in total

1.  Beta-catenin signaling regulates barrier-specific gene expression in circumventricular organ and ocular vasculatures.

Authors:  Yanshu Wang; Mark F Sabbagh; Xiaowu Gu; Amir Rattner; John Williams; Jeremy Nathans
Journal:  Elife       Date:  2019-04-01       Impact factor: 8.140

Review 2.  Is heterotopic ossification getting nervous?: The role of the peripheral nervous system in heterotopic ossification.

Authors:  Eleanor L Davis; Alan R Davis; Zbigniew Gugala; Elizabeth A Olmsted-Davis
Journal:  Bone       Date:  2017-07-15       Impact factor: 4.398

3.  Comparison of organ-specific endothelial cells in terms of microvascular formation and endothelial barrier functions.

Authors:  Hiroyuki Uwamori; Yuuichi Ono; Tadahiro Yamashita; Ken Arai; Ryo Sudo
Journal:  Microvasc Res       Date:  2018-11-22       Impact factor: 3.514

Review 4.  Blood-brain barrier dysfunction in ischemic stroke: targeting tight junctions and transporters for vascular protection.

Authors:  Wazir Abdullahi; Dinesh Tripathi; Patrick T Ronaldson
Journal:  Am J Physiol Cell Physiol       Date:  2018-06-27       Impact factor: 4.249

5.  Virus entry and replication in the brain precedes blood-brain barrier disruption during intranasal alphavirus infection.

Authors:  Matthew D Cain; Hamid Salimi; Yongfeng Gong; Lihua Yang; Samantha L Hamilton; James R Heffernan; Jianghui Hou; Mark J Miller; Robyn S Klein
Journal:  J Neuroimmunol       Date:  2017-05-01       Impact factor: 3.478

6.  In situ molecular characterization of endoneurial microvessels that form the blood-nerve barrier in normal human adult peripheral nerves.

Authors:  Xuan Ouyang; Chaoling Dong; Eroboghene E Ubogu
Journal:  J Peripher Nerv Syst       Date:  2019-06-04       Impact factor: 3.494

7.  Effects of Platelet-Activating Factor on Brain Microvascular Endothelial Cells.

Authors:  Eugen Brailoiu; Christine L Barlow; Servio H Ramirez; Mary E Abood; G Cristina Brailoiu
Journal:  Neuroscience       Date:  2018-03-06       Impact factor: 3.590

Review 8.  Impaired tissue barriers as potential therapeutic targets for Parkinson's disease and amyotrophic lateral sclerosis.

Authors:  Xin Fang
Journal:  Metab Brain Dis       Date:  2018-04-22       Impact factor: 3.584

Review 9.  A role for pericytes in chronic pain?

Authors:  Alexandra M Durrant; Matthew N Swift; Nicholas Beazley-Long
Journal:  Curr Opin Support Palliat Care       Date:  2018-06       Impact factor: 2.302

Review 10.  Early to Long-Term Alterations of CNS Barriers After Traumatic Brain Injury: Considerations for Drug Development.

Authors:  Beatriz Rodriguez-Grande; Aleksandra Ichkova; Sighild Lemarchant; Jerome Badaut
Journal:  AAPS J       Date:  2017-09-13       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.